Austrian Breast & Colorectal Cancer Study Group

Science from the heart of Europe

New E-Learning on „ADCs in Breast Cancer Treatment“

In July 2021, the ABCSG will release a new e-learning on „ADCs in BC Treatment“. This joint project with Daiichi Sankyo and AstraZeneca is also exceptional because, in addition to two contributions from renowned ABCSG experts, a Daiichi Sankyo expert will also contribute a virtual lecture. In a subsequent joint discussion with more ABCSG experts, the topic will be discussed in detail. Find the program of the e-learning below. The e-learning will be published in the ABCSG Members area in mid-July. Information will be available via the ABCSG Mailing and here on the website.

The E-Learning will be approved with 2 DFP points.

Experts on Tour goes digital – neues E-Learning ab Juli

15. Interdisziplinärer MAMMA-DISKURS – Registrierung geöffnet

Bereits zum 15. Mal wird heuer der alljährliche Mamma-Diskurs stattfinden, veranstaltet von der ABCSG in Kooperation mit der Österreichischen Gesellschaft für Senologie.

30. Jahrestagung der ABCSG

Dienstag, 2. bis Sonntag 7. Nov. 2021:
ABCSG Studien Specials & Educationals (on demand)

Freitag, 5. November:
Spotlights & Diskussionen (Streaming)

„SCIENCE NEWS“ vom ESMO Breast Cancer 2021

Die „Science News“ Kongressberichterstattung liefert Ihnen eine Zusammenfassung des European Society for Medical Oncology (ESMO) Breast Cancer Virtual Congress 2021. Der ESMO BC Kongress findet heuer virtuell vom 5. bis 8. Mai statt.

CDK 4/6 Inhibitors: Nuance or Difference: 22 April 2021

Cyclin-dependent kinase (CDK) 4/6 inhibitors are a new, yet meanwhile well-established class of therapeutic agents that improve the outcomes of patients with hormone receptor-positive breast cancer.

DATEN-FAKTEN: KONSEQUENZEN?